AGO2 and prostate carcinoma: There was an upregulation of AGO2 expression in an estrogen receptor α-negative breast cancer cell line, in prostate cancer as well as in esophageal squamous cell carcinoma tissue, which indicates that AGO2 plays a key role in tumorigenesis [16,17].